An AI agent chose a gene therapy and injected it into a live mouse using a robotic arm, according to WIRED. The biotech startup Exin Therapeutics let the agent choose the treatment. The report omits the therapy's target, mouse count and results beyond the successful injection.
An AI agent selected a gene therapy and successfully injected it into a live mouse, a demonstration that points to how automated systems could change the way research labs operate.
How did an AI agent inject gene therapy into a mouse?
Which company was involved in the AI gene therapy experiment?
The setup pairs an AI agent with a robotic arm and an injector. According to WIRED, the agent controlled the rig as it carried out what a caption describes as brain surgery on a mouse. The photo of the setup was provided by Exin Therapeutics, Inc., a biotech startup that let the agent choose the treatment.
Why does an AI agent performing lab procedures matter?
WIRED framed the experiment as a glimpse of where research may be heading. The procedure combines a decision-making system with physical lab equipment, which is the part that makes the test stand out. An agent that can both choose a treatment and deliver it removes the human from steps that have traditionally required a trained hand at the bench.
The report did not include details on the therapy's target, the number of mice involved or the results of the treatment beyond the successful injection.
Dieser Artikel wurde mit Unterstützung von KI verfasst.
News Factory APP - agentische News für besseres SEO & AEO.